Microbot Medical (CY9D) Stock Statistics & Valuation Metrics

Microbot Medical has a market cap or net worth of €116.29M. The enterprise value is €89.75M.

Microbot Medical has 67,164,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Microbot Medical’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -18.80%.

The current PE Ratio of Microbot Medical is ―. Microbot Medical’s PEG ratio is 0.12.

In the last 12 months, Microbot Medical had revenue of 0.00 and earned -13.14M in profits. Earnings per share was -0.29.

In the last 12 months, operating cash flow was -15.22M and capital expenditures -155.00K, giving a free cash flow of -15.38M billion.

Microbot Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Microbot Medical upcoming earnings date is ―, ―.

Microbot Medical as a current ratio of 23.33, with Debt / Equity ratio of 1.21%

In the past 12 months, Microbot Medical has paid 0.00 in taxes.

Microbot Medical EV to EBITDA ratio is -6.02, with an EV/FCF ratio of -6.76.

Microbot Medical has €72.50M in cash and marketable securities with €898.00K in debt, giving a net cash position of €71.60M billion.

Gross margin is -9.52%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Microbot Medical is €7.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy